1. Home
  2. AAOI vs BCAX Comparison

AAOI vs BCAX Comparison

Compare AAOI & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAOI
  • BCAX
  • Stock Information
  • Founded
  • AAOI 1997
  • BCAX 2018
  • Country
  • AAOI United States
  • BCAX United States
  • Employees
  • AAOI N/A
  • BCAX N/A
  • Industry
  • AAOI Semiconductors
  • BCAX
  • Sector
  • AAOI Technology
  • BCAX
  • Exchange
  • AAOI Nasdaq
  • BCAX NYSE
  • Market Cap
  • AAOI 707.6M
  • BCAX 670.9M
  • IPO Year
  • AAOI 2013
  • BCAX 2024
  • Fundamental
  • Price
  • AAOI $14.67
  • BCAX $12.97
  • Analyst Decision
  • AAOI Buy
  • BCAX Buy
  • Analyst Count
  • AAOI 4
  • BCAX 7
  • Target Price
  • AAOI $25.50
  • BCAX $29.67
  • AVG Volume (30 Days)
  • AAOI 3.1M
  • BCAX 586.0K
  • Earning Date
  • AAOI 05-08-2025
  • BCAX 05-20-2025
  • Dividend Yield
  • AAOI N/A
  • BCAX N/A
  • EPS Growth
  • AAOI N/A
  • BCAX N/A
  • EPS
  • AAOI N/A
  • BCAX N/A
  • Revenue
  • AAOI $308,551,000.00
  • BCAX N/A
  • Revenue This Year
  • AAOI $113.56
  • BCAX N/A
  • Revenue Next Year
  • AAOI $64.07
  • BCAX N/A
  • P/E Ratio
  • AAOI N/A
  • BCAX N/A
  • Revenue Growth
  • AAOI 50.30
  • BCAX N/A
  • 52 Week Low
  • AAOI $6.70
  • BCAX $8.91
  • 52 Week High
  • AAOI $44.50
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • AAOI 53.00
  • BCAX N/A
  • Support Level
  • AAOI $13.31
  • BCAX N/A
  • Resistance Level
  • AAOI $15.40
  • BCAX N/A
  • Average True Range (ATR)
  • AAOI 1.15
  • BCAX 0.00
  • MACD
  • AAOI 0.55
  • BCAX 0.00
  • Stochastic Oscillator
  • AAOI 85.52
  • BCAX 0.00

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: